IP Library › Granted Patent US 11,497,862
Granted Patent B2
US 11,497,862 · App. 16/944,080 · Granted Nov 15, 2022

Intranasal drug delivery device, system, and process

Inventors: David James Alt (North Vancouver, CA); Kenneth Colin MacNarin Irving (Victoria, CA); James Patrick Jackson (Victoria, CA); Peter Oxley (Rothesay, CA); Kenza Elizabeth Coubrough (Seattle, WA)
Assignee: Rocket Science Health Corp.
A61M11/007A61M15/0036A61M15/08A61M2205/52A61M2205/609A61M2205/8281A61M2206/11A61M2210/0618
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,497,862
App. No.
16/944,080
Granted
Nov 15, 2022
Kind
B2
Abstract

Embodiments relate to an intranasal drug delivery device, system, and process. The drug delivery device can have a compliant/flexible soft nib. The drug delivery device can have an actuator and shot chamber. The drug delivery device can have a non-air interface mechanically pressurized fluid reservoir. The drug delivery device can have a facial or device recognition application to prevent intentional or unintentional misuse.

Claims (18)

1. An intranasal fluid delivery device comprising:

(a) a compliant dispensing tip for dispensing a fluid, the compliant dispensing tip coupled to a hollow needle;

(b) a shot chamber for containing the fluid, the shot chamber comprising a diaphragm disposed at a first end and a plunger disposed at a second end; and

(c) an actuator operatively coupled to a push rod moveable toward the second end of the shot chamber, wherein upon the actuator being engaged, the actuator allows the push rod to push against the plunger, causing the shot chamber to move toward the needle such that the needle punctures the diaphragm, the plunger then exerting pressure on the fluid in the shot chamber such that the fluid flows out of the needle into the compliant dispensing tip;

wherein the compliant dispensing tip comprises: a compliant and flexible soft nib; and a nostril stop that is configured to: (I) limit depth of insertion of the compliant and flexible soft nib into a nasal cavity of a user or patient; and (II) provide feedback to the user when the compliant and flexible soft nib reaches a location proximate to an olfactory region in the nasal cavity of the user or patient, wherein the compliant and flexible soft nib defines a channel therein for dispensing the fluid therefrom as a laminar flow and wherein: (i) the compliant and flexible soft nib is configured to conform with a nasal cavity of the user or patient and follows the septum of the user or patient and accommodates nasal cavity anatomy differences of the user or patient while being self-guided through an internal nasal geometry of the user or patient to a location proximate to an olfactory region in the user's or patient's nasal cavity; (ii) the nostril stop is configured to provide the feedback to the user that the compliant and flexible soft nib has reached a location proximate to an olfactory region in the user's or patient's nasal cavity; and (iii) the compliant and flexible soft nib (A) is configured to stop at the position proximate to the olfactory region in the user's or patient's nasal cavity and (B) is configured to precisely deliver the fluid to the olfactory region of the user or patient from the position proximate to the olfactory region in the user's or patient's nasal cavity.

2. The intranasal fluid delivery device of claim 1 , wherein the actuator comprises a locking mechanism, and wherein user engagement of the actuator releases the locking mechanism, allowing the push rod to push against the plunger, further wherein the locking mechanism comprises one or both of:

a) one or more tabs comprising a lock material, configured such that the locking mechanism is released by the user breaking the lock material; and

b) one or more pivotable tabs, configured such that the locking mechanism is released by the user pivoting the pivotable tabs.

3. The intranasal fluid delivery device of claim 2 , further comprising a spring in alignment with the push rod, wherein the locking mechanism is configured to maintain the spring under a pressure condition, wherein releasing the locking mechanism releases the spring from the pressure condition, causing the push rod to push against the plunger.

4. The intranasal fluid delivery device of claim 3 , further comprising a cocking mechanism configured to be activated by the user, wherein the intranasal fluid delivery device is configured such that when the user activates the cocking mechanism, pressure is applied to the spring and the spring is thereby placed under the pressure condition.

5. The intranasal fluid delivery device of claim 1 , comprising a cartridge configured for containing, or containing, the fluid, wherein the cartridge comprises the shot chamber, the diaphragm, and the plunger.

6. The intranasal fluid delivery device of claim 5 , wherein the cartridge is a removable and replaceable component of the intranasal fluid delivery device.

7. The intranasal fluid delivery device of claim 1 , further comprising a housing, chassis or outer body.

8. The intranasal fluid delivery device of claim 7 , wherein the housing, chassis or outer body is configured: (a) to be removable in whole or in part from other components of the intranasal fluid delivery device; (b) to allow for the user to gain access to a cartridge configured for containing, or containing, the fluid, or (c) a combination thereof.

9. The intranasal fluid delivery device of claim 1 , further comprising a stopping mechanism configured to limit a travel distance of the push rod.

10. The intranasal fluid delivery device of claim 1 , further comprising a dampening mechanism configured to generate a controlled velocity profile of the fluid dispensed from the compliant dispensing tip, and wherein the dampening mechanism comprises at least one of a magnet, a spring, a viscous dampener, a sealed chamber with an airflow restriction, a container of compressed gas, a valve, a motor, an elastomeric chamber, and a flow restriction device.

11. The intranasal fluid delivery device of claim 1 , further configured such that, upon the needle puncturing the diaphragm the shot chamber then bottoms out and the plunger then exerts pressure on the fluid in the shot chamber such that the fluid flows out of the needle into the compliant dispensing tip.

12. The intranasal fluid delivery device of claim 1 , wherein the compliant dispensing tip, and the compliant and flexible nib, complies with the internal nasal geometry of the user or patient to guide a delivery end of the compliant dispensing tip proximate to the olfactory region in the user's or patient's nasal cavity.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 22, 2020
From: FORTITUDE CORP.
To: ROCKET SCIENCE HEALTH CORP.
Reel/Frame 053847/0174 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 2, 2020
From: ALT, DAVID JAMES; IRVING, KENNETH COLIN MACNARIN; JACKSON, JAMES PATRICK; OXLEY, PETER; COUBROUGH, KENZA ELIZABETH
To: FORTITUDE CORP.
Reel/Frame 053670/0887 →
Continuity (4)
Continuation PCTCA2019050455 · Apr 12, 2019
Provisional Application 62774444 · Dec 3, 2018
Provisional Application 62656463 · Apr 12, 2018
Related Publication 20200353183A1 · Nov 12, 2020
Cited By (1)
US 1,080,857